A member of Forkhead family transcription factor, FKHRL1, is one of the downstream molecules of phosphatidylinositol 3-kinase-Akt activation pathway in erythropoietin signal transduction
Y. Kashii et al., A member of Forkhead family transcription factor, FKHRL1, is one of the downstream molecules of phosphatidylinositol 3-kinase-Akt activation pathway in erythropoietin signal transduction, BLOOD, 96(3), 2000, pp. 941-949
The phosphatidylinositol 3-kinase (PI3K) signaling pathway is important for
the regulation of a number of cellular responses. Serine/threonine kinase
AM (protein kinase B; PKB) Is downstream of PI3K and activated by growth fa
ctors. This study found that erythropoietin (EPO) induced tyrosine phosphor
ylation of AM in a time- and dose-dependent manner in EPO-dependent human l
eukemia cell line UT-7/EPO, In vitro kinase assay using histone H2B and glu
cose synthase kinase as substrates demonstrated that AM was actually activa
ted by EPO, EPO-induced phosphorylation of AM was completely blocked by a P
I3K-specific inhibitor, LY294002, at 10 mu mol/L, indicating that activatio
n of AM by EPO is dependent on PI3K activity. In addition, overexpression o
f the constitutively active form of AM on UT-7/EPO cells partially blocked
apoptosis induced by withdrawal of EPO from the culture medium. This findin
g suggested that the PI3K-Akt activation pathway plays some role in the ant
iapoptotic effect of EPO, EPO induced phosphorylation of a member of the tr
ancription factor Forkhead family, FKHRL1, at threonine 32 and serine 253 i
n a dose- and time-dependent manner in UT-7/EPO cells. Moreover, results sh
owed that AM kinase activated by EPO directly phosphorylated FKHRL1 protein
and that FKHRL1 phosphorylation was completely dependent on PI3K activity
as Is the case for AW, In conjunction with the evidence that FKHRL1 is expr
essed in normal human erythroid progenitor cells and erythroblasts, the res
ults suggest that FKHRL1 plays an important role in erythropoiesis as one o
f the downstream target molecules of PI3K-Akt. (C) 2000 by The American Soc
iety of Hematology.